Seven Eight Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,474
Closed -$729K 746
2024
Q1
$729K Buy
+5,474
New +$710K 0.08% 371
2023
Q2
Sell
-4,884
Closed -$691K 536
2023
Q1
$691K Sell
4,884
-4,379
-47% -$627K 0.14% 192
2022
Q4
$1.45M Sell
9,263
-4,357
-32% -$626K 0.38% 80
2022
Q3
$1.66M Buy
+13,620
New +$1.79M 0.33% 82
2022
Q2
Sell
-24,541
Closed -$3.36M 436
2022
Q1
$3.36M Buy
+24,541
New +$3.42M 0.45% 64
2021
Q2
Sell
-9,980
Closed -$1.19M 608
2021
Q1
$1.19M Hold
9,980
0.27% 133
2020
Q4
$1.19M Buy
9,980
+2,100
+27% +$256K 0.27% 135
2020
Q3
$902K Buy
+7,880
New +$931K 0.2% 194
2020
Q2
Sell
-25,400
Closed -$2.04M 383
2020
Q1
$2.04M Buy
+25,400
New +$2.63M 0.52% 48
2019
Q4
Sell
-7,062
Closed -$756K 653
2019
Q3
$756K Buy
+7,062
New +$725K 0.04% 463
2018
Q4
Sell
-45,398
Closed -$4.9M 573
2018
Q3
$4.9M Buy
+45,398
New +$4.98M 0.3% 95
2017
Q4
Sell
-33,398
Closed -$3.11M 480
2017
Q3
$3.11M Buy
+33,398
New +$3.55M 0.38% 87
2017
Q1
Sell
-698
Closed -$64K 553
2016
Q4
$64K Buy
+698
New +$60.2K 0.01% 491
2015
Q4
Sell
-3,898
Closed -$240K 581
2015
Q3
$240K Buy
+3,898
New +$272K 0.21% 163
2014
Q4
Sell
-1,900
Closed -$115K 533
2014
Q3
$115K Buy
+1,900
New +$117K 0.09% 299
2014
Q1
Sell
-4,500
Closed -$241K 332
2013
Q4
$241K Buy
+4,500
New +$267K 0.27% 114

Other funds holding DGX

Seven Eight Capital's DGX Position: Q2 2024 in Review

Seven Eight Capital sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 5,474 shares — an estimated $729K sold.

Seven Eight Capital first reported a position in DGX in Q4 2013 and held it in 16 quarters. The position peaked at $4.9M in Q3 2018. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Seven Eight Capital reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 5,474 Quest Diagnostics shares in Q2 2024, an estimated $729K.
  • Seven Eight Capital first reported a position in Quest Diagnostics in Q4 2013 and held it in 16 quarters.
  • Seven Eight Capital's Quest Diagnostics position peaked at $4.9M in Q3 2018.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.